7-139872324-G-A
Variant summary
Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2
The NM_001061.7(TBXAS1):c.179G>A(p.Arg60His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00183 in 1,613,452 control chromosomes in the GnomAD database, including 5 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another nucleotide change resulting in same amino acid change has been previously reported as Likely benignin UniProt. Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R60C) has been classified as Likely benign.
Frequency
Consequence
NM_001061.7 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -9 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
TBXAS1 | NM_001061.7 | c.179G>A | p.Arg60His | missense_variant | 2/13 | ENST00000448866.7 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
TBXAS1 | ENST00000448866.7 | c.179G>A | p.Arg60His | missense_variant | 2/13 | 1 | NM_001061.7 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00131 AC: 200AN: 152100Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00171 AC: 430AN: 251374Hom.: 1 AF XY: 0.00173 AC XY: 235AN XY: 135852
GnomAD4 exome AF: 0.00188 AC: 2753AN: 1461234Hom.: 5 Cov.: 31 AF XY: 0.00186 AC XY: 1350AN XY: 726948
GnomAD4 genome AF: 0.00131 AC: 200AN: 152218Hom.: 0 Cov.: 32 AF XY: 0.00136 AC XY: 101AN XY: 74416
ClinVar
Submissions by phenotype
not provided Uncertain:1Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 15, 2023 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Feb 01, 2018 | - - |
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Oct 20, 2023 | Variant summary: TBXAS1 c.179G>A (p.Arg60His) results in a non-conservative amino acid change in the encoded protein sequence. Three of five in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 0.0017 in 251374 control chromosomes in the gnomAD database, including 1 homozygote. c.179G>A has been reported in the literature in an individual affected with a bleeding disorder without strong evidence of causality (e.g. Leine_2017). This report does not provide unequivocal conclusions about association of the variant with Ghosal Hematodiaphyseal Dysplasia. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publication has been ascertained in the context of this evaluation (PMID: 28748566). Two submitters have cited clinical-significance assessments for this variant to ClinVar after 2014, classifying variant as benign (n=1) or uncertain significance (n=1). Based on the evidence outlined above, the variant was classified as uncertain significance. - |
TBXAS1-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Dec 08, 2023 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at